Colgate on acquisitions
This article was originally published in The Rose Sheet
Executive Summary
Colgate-Palmolive would "not easily move into" OTC or pharmaceutical categories, CEO Reuben Mark states during June 1 Sanford Bernstein Strategic Decisions Conference. Colgate has been identified as a potential bidder for Pfizer's Consumer Healthcare unit, which in addition to OTCs includes the Listerine oral care brand (1"The Rose Sheet" May 29, 2006, p. 4). Pfizer has expressed it is not interested in selling its brands individually. Separately, Mark notes the firm's advertising spend will be up a record 13%-14% in 2006. Colgate spent $297.1 mil. behind its global brands in the first quarter (2"The Rose Sheet" March 14, 2006, p. 4). The company also placed a record amount behind advertising last year, with spending up 11.5%, exec notes...
You may also be interested in...
Pfizer Weighs Options For OTC Division As Investors Line Up For Purchase
While Pfizer considers whether to sell its Consumer Healthcare unit or spin it off to shareholders, potential buyers are placing bids with an eye toward an early June deadline
Colgate Total Ad Revamp Aims To Underscore Disease Prevention Claims
Colgate will launch new advertisements for Colgate Total toothpaste this year, according to Colgate-Palmolive President and Chief Operating Officer Ian Cook. The company plans to reposition the brand with advertising underscoring the toothpaste's effectiveness against gum and tooth diseases through testimonials from dental professionals, he explained during a May 10 analyst call
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.